Top Markets
#1 Bedrock Bedrock +50.85%
#2 pippin pippin +21.68%
#3 IQ IQ +20.70%
#4 Naoris Protocol Naoris Protocol +17.39%
#5 Irys Irys +16.18%
#6 Magma Finance Magma Finance +15.58%
#7 ETHGas ETHGas +15.36%
#8 Aria.AI Aria.AI +15.19%
#9 パンチ (Punch) パンチ (Punch) +14.59%
#10 Bitway Bitway +12.30%
Coin of the day
Bedrock Bedrock
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rang în acțiuni #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Preț acțiune
$0.16328419
Capitalizare de piață
$204.14K
Schimbare (1 zi)
4.35%
Schimbare (1 an)
102.45%
Țară
GB
Tranzacționează Fusion Antibodies plc (FAB)

Categorie

Healthcare
Raport P/S pentru Fusion Antibodies plc (FAB)
Raport P/S la data de March 2026 TTM: 9.79
Conform celor mai recente rapoarte financiare și prețului acțiunilor Fusion Antibodies plc, raportul P/S actual (TTM) este 9.79. La sfârșitul anului 2024, compania avea un P/S de 1.88.
Istoricul raportului P/S pentru Fusion Antibodies plc din 2013 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 9.79 226.39%
2025 3.00 59.38%
2024 1.88 -45.47%
2023 3.45 6.43%
2022 3.24 -66.20%
2021 9.60 78.11%
2020 5.39 86.72%
2019 2.89 -54.34%
2018 6.32 -55.67%
2017 14.25 -22.61%
2016 18.42 -38.61%
2015 30.00 -20.48%
2014 37.73 -43.99%
2013 67.37 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.55 -63.73%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 1.13%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 -44.83%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 -37.31%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.90 31.71%
NL